Condition: Glioma · Sponsor: M.D. Anderson Cancer Center
The goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who have received standard-of-care radiation therapy.
This description comes directly from the study's public registry record.
Gregory Friedman, MD · 713-835-4467 · gkfriedman@mdanderson.org
Kara Kachurak, PNP · 713-835-4467 · kgkachurak@mdanderson.org
Always discuss trial participation with your own doctor first.
| The University of Texas M. D. Anderson Cancer Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07076498